Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Intraoperative Imaging in Hepatopancreatobiliary Surgery

T. Husarova, WM. MacCuaig, IS. Dennahy, EJ. Sanderson, BH. Edil, A. Jain, MM. Bonds, MW. McNally, K. Menclova, J. Pudil, P. Zaruba, R. Pohnan, CE. Henson, WE. Grizzle, LR. McNally

. 2023 ; 15 (14) : . [pub] 20230720

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc23015685

Grantová podpora
f31ca261044 NCI NIH HHS - United States
R01CA205941 NCI NIH HHS - United States
U54CA118949 NCI NIH HHS - United States
p30ca225520 NCI NIH HHS - United States
R01EB034731 NCI NIH HHS - United States

Hepatopancreatobiliary surgery belongs to one of the most complex fields of general surgery. An intricate and vital anatomy is accompanied by difficult distinctions of tumors from fibrosis and inflammation; the identification of precise tumor margins; or small, even disappearing, lesions on currently available imaging. The routine implementation of ultrasound use shifted the possibilities in the operating room, yet more precision is necessary to achieve negative resection margins. Modalities utilizing fluorescent-compatible dyes have proven their role in hepatopancreatobiliary surgery, although this is not yet a routine practice, as there are many limitations. Modalities, such as photoacoustic imaging or 3D holograms, are emerging but are mostly limited to preclinical settings. There is a need to identify and develop an ideal contrast agent capable of differentiating between malignant and benign tissue and to report on the prognostic benefits of implemented intraoperative imaging in order to navigate clinical translation. This review focuses on existing and developing imaging modalities for intraoperative use, tailored to the needs of hepatopancreatobiliary cancers. We will also cover the application of these imaging techniques to theranostics to achieve combined diagnostic and therapeutic potential.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015685
003      
CZ-PrNML
005      
20231020093443.0
007      
ta
008      
231010s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers15143694 $2 doi
035    __
$a (PubMed)37509355
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Husarova, Tereza $u Department of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA $u Department of Surgery, Military University Hospital Prague, 16902 Prague, Czech Republic $1 https://orcid.org/0000000176722286
245    10
$a Intraoperative Imaging in Hepatopancreatobiliary Surgery / $c T. Husarova, WM. MacCuaig, IS. Dennahy, EJ. Sanderson, BH. Edil, A. Jain, MM. Bonds, MW. McNally, K. Menclova, J. Pudil, P. Zaruba, R. Pohnan, CE. Henson, WE. Grizzle, LR. McNally
520    9_
$a Hepatopancreatobiliary surgery belongs to one of the most complex fields of general surgery. An intricate and vital anatomy is accompanied by difficult distinctions of tumors from fibrosis and inflammation; the identification of precise tumor margins; or small, even disappearing, lesions on currently available imaging. The routine implementation of ultrasound use shifted the possibilities in the operating room, yet more precision is necessary to achieve negative resection margins. Modalities utilizing fluorescent-compatible dyes have proven their role in hepatopancreatobiliary surgery, although this is not yet a routine practice, as there are many limitations. Modalities, such as photoacoustic imaging or 3D holograms, are emerging but are mostly limited to preclinical settings. There is a need to identify and develop an ideal contrast agent capable of differentiating between malignant and benign tissue and to report on the prognostic benefits of implemented intraoperative imaging in order to navigate clinical translation. This review focuses on existing and developing imaging modalities for intraoperative use, tailored to the needs of hepatopancreatobiliary cancers. We will also cover the application of these imaging techniques to theranostics to achieve combined diagnostic and therapeutic potential.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a MacCuaig, William M $u Department of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
700    1_
$a Dennahy, Isabel S $u Department of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
700    1_
$a Sanderson, Emma J $u Department of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
700    1_
$a Edil, Barish H $u Department of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
700    1_
$a Jain, Ajay $u Department of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
700    1_
$a Bonds, Morgan M $u Department of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
700    1_
$a McNally, Molly W $u Department of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
700    1_
$a Menclova, Katerina $u Department of Surgery, Military University Hospital Prague, 16902 Prague, Czech Republic
700    1_
$a Pudil, Jiri $u Department of Surgery, Military University Hospital Prague, 16902 Prague, Czech Republic
700    1_
$a Zaruba, Pavel $u Department of Surgery, Military University Hospital Prague, 16902 Prague, Czech Republic
700    1_
$a Pohnan, Radek $u Department of Surgery, Military University Hospital Prague, 16902 Prague, Czech Republic
700    1_
$a Henson, Christina E $u Department of Radiation Oncology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA $1 https://orcid.org/0000000254194125
700    1_
$a Grizzle, William E $u Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
700    1_
$a McNally, Lacey R $u Department of Surgery, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 15, č. 14 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37509355 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20231020093437 $b ABA008
999    __
$a ok $b bmc $g 1997227 $s 1202047
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 15 $c 14 $e 20230720 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
GRA    __
$a f31ca261044 $p NCI NIH HHS $2 United States
GRA    __
$a R01CA205941 $p NCI NIH HHS $2 United States
GRA    __
$a U54CA118949 $p NCI NIH HHS $2 United States
GRA    __
$a p30ca225520 $p NCI NIH HHS $2 United States
GRA    __
$a R01EB034731 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20231010

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...